Titre : | Global overview of injecting drug use and HIV infection among injecting drug users |
Titre traduit : | (Une vue globale de l'usage de drogues par injection et de l'infection VIH parmi les usagers de drogues injectables.) |
Auteurs : | C. ACEIJAS ; G. V. STIMSON ; M. HICKMAN ; T. RHODES |
Type de document : | Périodique |
Année de publication : | 2004 |
Format : | 2295-2303 / tabl. |
Note générale : |
AIDS, 2004, 18, (17), 2295-2303 |
Langues: | Anglais |
Discipline : | EPI (Epidémiologie / Epidemiology) |
Mots-clés : |
Thésaurus mots-clés USAGER ; INJECTION ; PREVALENCE ; VIHThésaurus géographique EUROPE ; ASIE ; AMERIQUE DU SUD ; CARAIBES ; AMERIQUE DU NORD ; AFRIQUE |
Résumé : |
ENGLISH : Objective: To provide global estimates of the prevalence of injecting drug use (IDU) and HIV prevalence among IDU, in particular to provide estimates for developing and transitional countries. Methods: Collation and review of existing estimates of IDU prevalence and HIV prevalence from published and unpublished documents for the period 1998-2003. The strength of evidence for the information was assessed based on the source and type of study. Results: Estimates of IDU prevalence were available for 130 countries. The number of IDU worldwide was estimated as approximately 13.2 million. Over ten million (78%) live in developing and transitional countries (Eastern Europe and Central Asia, 3.1 million; South and South-east Asia, 3.3 million; East-Asia and Pacific, 2.3 million). Estimates of HIV prevalence were available for 78 countries. HIV prevalence among IDU of over 20% was reported for at least one site in 25 countries and territories: Belarus, Estonia, Kazakhstan, Russia, Ukraine, Italy, Netherlands, Portugal, Serbia and Montenegro, Spain, Libya, India, Indonesia, Malaysia, Myanmar, Nepal, Thailand, Viet Nam, China, Argentina, Brazil, Uruguay, Puerto Rico, USA and Canada. Conclusions: These findings update previous assessments of the number of countries with IDU and HIV-infected IDU, and the previous quantitative global estimates of the prevalence of IDU. However, gaps remain in the information and the strength of the evidence often was weak. (Author' s abstract) |
Note de contenu : | tabl. |
Domaine : | Drogues illicites / Illicit drugs |
Affiliation : |
Centre for Research on Drugs and Health Behaviour, Imperial College, Fac. Medicine, St Dunstan's Road, London, W6 8RP Royaume-Uni. United Kingdom. |
Numéro Toxibase : | 208159 |
Centre Emetteur : | 02 Coordonnateur |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil